China NT Pharma Group Co (HKSE:01011) EPS (Basic): HK$-0.05 (TTM As of Dec. 2025)


HKSE:01011 China NT Pharma Group Co Ltd HKSE:01011
14 GF Score
Price HK$0.40
! 4 Warning Signs
View Full Analysis

What is China NT Pharma Group Co EPS (Basic)?

China NT Pharma Group Co HKSE:01011 14 EPS (Basic) is HK$-0.05 as of Dec. 2025. GuruFocus rates HKSE:01011 with a GF Score™ of 14/100. The stock has 4 warning signs investors should review.

China NT Pharma Group Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.05.

China NT Pharma Group Co's EPS (Diluted) for the six months ended in Dec. 2025 was HK$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.05.

China NT Pharma Group Co's EPS without NRI for the six months ended in Dec. 2025 was HK$-0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.07.

During the past 3 years, the average EPS without NRI Growth Rate was 39.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 48.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, China NT Pharma Group Co's highest 3-Year average EPS without NRI Growth Rate was 155.70% per year. The lowest was -71.10% per year. And the median was 48.30% per year.

China NT Pharma Group Co  (HKSE:01011) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

China NT Pharma Group Co EPS (Basic) Related Terms

China NT Pharma Group Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for China NT Pharma Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China NT Pharma Group Co EPS (Basic) Chart

China NT Pharma Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.97 -0.39 -0.66 -0.22 -0.05

China NT Pharma Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 0.00 -0.22 -0.03 -0.01
HKSE:01011
14GF Score
China NT Pharma Group Co Ltd HKSE:01011
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China NT Pharma Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

China NT Pharma Group Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-28.768-0)/616.936
=-0.05

China NT Pharma Group Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-10.092-0)/675.195
=-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$-0.05 mean?
China NT Pharma Group Co (HKSE:01011) has a EPS (Basic) of HK$-0.05 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on China NT Pharma Group Co and its competitors.
Is China NT Pharma Group Co's EPS (Basic) too high?
China NT Pharma Group Co's current EPS (Basic) is HK$-0.05. Overall, China NT Pharma Group Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does China NT Pharma Group Co's EPS (Basic) compare to ZTS?
China NT Pharma Group Co's EPS (Basic) of HK$-0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on China NT Pharma Group Co and its competitors. China NT Pharma Group Co's current EPS (Basic) is HK$-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China NT Pharma Group Co stock overvalued right now?
China NT Pharma Group Co (HKSE:01011) has a current EPS (Basic) of HK$-0.05. The current EPS (Basic) is HK$-0.05. China NT Pharma Group Co's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For China NT Pharma Group Co (HKSE:01011), the current EPS (Basic) is HK$-0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China NT Pharma Group Co Business Description

Address 168-200 Connaught Road, Unit 2102, 21st Floor, West Tower, Shun Tak Centre, Central, Hong Kong, HKG
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The Group's operations are regarded as having two operating and reportable segments, namely Agency Services and Healthcare Related Services. The company generates maximum of its revenue from Healthcare Related Services.
14GF Score

Get the complete analysis for HKSE:01011

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.40
Price